Detalhe da pesquisa
1.
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Rheumatology (Oxford)
; 61(12): 4786-4796, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348643
2.
Mapping and predicting mortality from systemic sclerosis.
Ann Rheum Dis
; 76(11): 1897-1905, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28835464
3.
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID).
J Rheumatol
; 39(11): 2153-6, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22984269
4.
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).
Arthritis Res Ther
; 13(3): R75, 2011 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21569519